Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (351-360 of 475) with videos related to

Pageof 48
Sort By:
European Radiology|January 28, 2026
Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validationEduardo H P Pooch, Georgios Agrotis, Lishan Cai, et al.
Science (New York, N.Y.)|March 17, 2022
Early detection of cancerDavid Crosby, Sangeeta Bhatia, Kevin M Brindle, et al.
The Journal of Urology|October 6, 2020
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?Luis Ribeiro, Thomas Stonier, Luke Stroman, et al.
Urology|February 25, 2003
Benign prostatic hyperplasia: a progressive disease of aging menMark Emberton, Gerald L Andriole, Jean de la Rosette, et al.
European Urology|May 4, 2020
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort StudyVasilis Stavrinides, Francesco Giganti, Bruce Trock, et al.
Medical Physics|March 20, 2023
Prostate cancer segmentation from MRI by a multistream fusion encoderMingjie Jiang, Baohua Yuan, Weixuan Kou, et al.
Plos One|February 24, 2022
The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analysesTeresa Marsden, Neil McCartan, Louise Brown, et al.
European Radiology|September 18, 2014
Logistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRINikolaos Dikaios, Jokha Alkalbani, Harbir Singh Sidhu, et al.
BJU International|May 21, 2014
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapyCaroline M Moore, Abel-Rahmene Azzouzi, Eric Barret, et al.
European Radiology|May 20, 2017
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trialFrancesco Giganti, Caroline M Moore, Nicola L Robertson, et al.
Pageof 48

Showing results (351-360 of 475) with videos related to

Sort By:
Pageof 48
European Radiology|January 28, 2026
Semi-supervised learning in prostate MRI tumor detection approaches fully supervised performance on external validationEduardo H P Pooch, Georgios Agrotis, Lishan Cai, et al.
Science (New York, N.Y.)|March 17, 2022
Early detection of cancerDavid Crosby, Sangeeta Bhatia, Kevin M Brindle, et al.
The Journal of Urology|October 6, 2020
Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?Luis Ribeiro, Thomas Stonier, Luke Stroman, et al.
Urology|February 25, 2003
Benign prostatic hyperplasia: a progressive disease of aging menMark Emberton, Gerald L Andriole, Jean de la Rosette, et al.
European Urology|May 4, 2020
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort StudyVasilis Stavrinides, Francesco Giganti, Bruce Trock, et al.
Medical Physics|March 20, 2023
Prostate cancer segmentation from MRI by a multistream fusion encoderMingjie Jiang, Baohua Yuan, Weixuan Kou, et al.
Plos One|February 24, 2022
The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analysesTeresa Marsden, Neil McCartan, Louise Brown, et al.
European Radiology|September 18, 2014
Logistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRINikolaos Dikaios, Jokha Alkalbani, Harbir Singh Sidhu, et al.
BJU International|May 21, 2014
Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapyCaroline M Moore, Abel-Rahmene Azzouzi, Eric Barret, et al.
European Radiology|May 20, 2017
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trialFrancesco Giganti, Caroline M Moore, Nicola L Robertson, et al.
Pageof 48